APA (7th ed.) Citation

L, Z., CL, N., CA, D., J, C., VM, L., T, P., . . . DJ, D. (2022). STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Neuro-oncology, 24(10), 1700. https://doi.org/10.1093/neuonc/noac093

Chicago Style (17th ed.) Citation

L, Zhang, et al. "STAT3 Is a Biologically Relevant Therapeutic Target in H3K27M-mutant Diffuse Midline Glioma." Neuro-oncology 24, no. 10 (2022): 1700. https://doi.org/10.1093/neuonc/noac093.

MLA (9th ed.) Citation

L, Zhang, et al. "STAT3 Is a Biologically Relevant Therapeutic Target in H3K27M-mutant Diffuse Midline Glioma." Neuro-oncology, vol. 24, no. 10, 2022, p. 1700, https://doi.org/10.1093/neuonc/noac093.